CHARLES A BAKER Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES A BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES A BAKER. CHARLES A BAKER is Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX).
CHARLES A BAKER in REGENERON PHARMACEUTICALS, INC.
Trading Symbol: REGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES A BAKER: Director
Holdings: 11,000 shares
Current Value: $3,934,590
Latest Transaction: Oct 03 2017
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHARLES A BAKER in REGENERON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2017 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.61 | 2,000 | 37,220 | 0 | |
Oct 03 2017 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 450.00 | 2,000 | 900,000 | 9,000 | 11 K to 9 K (-18.18 %) |
Oct 03 2017 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.61 | 2,000 | 37,220 | 11,000 | 9 K to 11 K (+22.22 %) |
Jan 05 2017 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 376.69 | 7,830 | 2,949,483 | 7,830 | |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.61 | 3,000 | 55,830 | 2,000 | |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 394.33 | 200 | 78,866 | 9,000 | 9.2 K to 9 K (-2.17 %) |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 393.64 | 600 | 236,184 | 9,200 | 9.8 K to 9.2 K (-6.12 %) |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 392.41 | 400 | 156,964 | 9,800 | 10.2 K to 9.8 K (-3.92 %) |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 391.36 | 1,200 | 469,632 | 10,200 | 11.4 K to 10.2 K (-10.53 %) |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 390.67 | 600 | 234,402 | 11,400 | 12 K to 11.4 K (-5.00 %) |
Dec 14 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.61 | 3,000 | 55,830 | 12,000 | 9 K to 12 K (+33.33 %) |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Sep 18 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.61 | 5,000 | 93,050 | 5,000 | |
Sep 18 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 550.00 | 5,000 | 2,750,000 | 9,000 | 14 K to 9 K (-35.71 %) |
Sep 18 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.61 | 5,000 | 93,050 | 14,000 | 9 K to 14 K (+55.56 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.61 | 5,000 | 93,050 | 10,000 | |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 457.21 | 200 | 91,442 | 9,000 | 9.2 K to 9 K (-2.17 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 456.36 | 700 | 319,452 | 9,200 | 9.9 K to 9.2 K (-7.07 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 455.48 | 1,536 | 699,617 | 9,900 | 11.4 K to 9.9 K (-13.43 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 454.38 | 1,999 | 908,306 | 11,436 | 13.4 K to 11.4 K (-14.88 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 453.71 | 265 | 120,233 | 13,435 | 13.7 K to 13.4 K (-1.93 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 452.45 | 300 | 135,735 | 13,700 | 14 K to 13.7 K (-2.14 %) |
Mar 26 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.61 | 5,000 | 93,050 | 14,000 | 9 K to 14 K (+55.56 %) |
Jan 05 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 23.84 | 15,000 | 357,600 | 0 | |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 313.40 | 100 | 31,340 | 9,000 | 9.1 K to 9 K (-1.10 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 312.29 | 600 | 187,374 | 9,100 | 9.7 K to 9.1 K (-6.19 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 311.46 | 1,200 | 373,752 | 9,700 | 10.9 K to 9.7 K (-11.01 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 310.80 | 600 | 186,480 | 10,900 | 11.5 K to 10.9 K (-5.22 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 308.25 | 400 | 123,300 | 11,500 | 11.9 K to 11.5 K (-3.36 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 307.65 | 300 | 92,295 | 11,900 | 12.2 K to 11.9 K (-2.46 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 305.25 | 200 | 61,050 | 12,200 | 12.4 K to 12.2 K (-1.61 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 304.42 | 300 | 91,326 | 12,400 | 12.7 K to 12.4 K (-2.36 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 303.64 | 300 | 91,092 | 12,700 | 13 K to 12.7 K (-2.31 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 302.90 | 100 | 30,290 | 13,000 | 13.1 K to 13 K (-0.76 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 301.12 | 700 | 210,784 | 13,100 | 13.8 K to 13.1 K (-5.07 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 300.09 | 10,200 | 3,060,918 | 13,800 | 24 K to 13.8 K (-42.50 %) |
Mar 25 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 23.84 | 15,000 | 357,600 | 24,000 | 9 K to 24 K (+166.67 %) |
Jan 06 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 273.67 | 12,750 | 3,489,293 | 12,750 | |
Jan 06 2014 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Gift | G | 0.00 | 590 | 0 | 0 | 590 to 0 (-100.00 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 19.69 | 15,000 | 295,350 | 0 | |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 319.13 | 400 | 127,652 | 9,000 | 9.4 K to 9 K (-4.26 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 318.27 | 700 | 222,789 | 9,400 | 10.1 K to 9.4 K (-6.93 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 317.48 | 900 | 285,732 | 10,100 | 11 K to 10.1 K (-8.18 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 316.54 | 1,200 | 379,848 | 11,000 | 12.2 K to 11 K (-9.84 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 315.51 | 800 | 252,408 | 12,200 | 13 K to 12.2 K (-6.15 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 314.31 | 2,608 | 819,720 | 13,000 | 15.6 K to 13 K (-16.71 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 313.47 | 3,705 | 1,161,406 | 15,608 | 19.3 K to 15.6 K (-19.18 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 312.53 | 3,887 | 1,214,804 | 19,313 | 23.2 K to 19.3 K (-16.75 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 311.59 | 300 | 93,477 | 23,200 | 23.5 K to 23.2 K (-1.28 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 309.73 | 100 | 30,973 | 23,500 | 23.6 K to 23.5 K (-0.42 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 308.91 | 100 | 30,891 | 23,600 | 23.7 K to 23.6 K (-0.42 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 302.46 | 300 | 90,738 | 23,700 | 24 K to 23.7 K (-1.25 %) |
Oct 02 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 19.69 | 15,000 | 295,350 | 24,000 | 9 K to 24 K (+166.67 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 15.80 | 15,000 | 237,000 | 0 | |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 257.99 | 300 | 77,397 | 9,000 | 9.3 K to 9 K (-3.23 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 255.16 | 200 | 51,032 | 9,300 | 9.5 K to 9.3 K (-2.11 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 254.10 | 756 | 192,100 | 9,500 | 10.3 K to 9.5 K (-7.37 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 253.50 | 908 | 230,178 | 10,256 | 11.2 K to 10.3 K (-8.13 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 252.32 | 4,748 | 1,198,015 | 11,164 | 15.9 K to 11.2 K (-29.84 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 251.67 | 3,938 | 991,076 | 15,912 | 19.9 K to 15.9 K (-19.84 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 250.06 | 4,150 | 1,037,749 | 19,850 | 24 K to 19.9 K (-17.29 %) |
Jun 12 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 15.80 | 15,000 | 237,000 | 24,000 | 9 K to 24 K (+166.67 %) |
Jan 03 2013 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 177.82 | 15,000 | 2,667,300 | 15,000 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 9.17 | 1,100 | 10,087 | 0 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 9.17 | 1,200 | 11,004 | 1,100 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 9.17 | 5,035 | 46,171 | 2,300 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 9.17 | 6,565 | 60,201 | 7,335 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 9.17 | 1,100 | 10,087 | 13,900 | |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 171.45 | 1,100 | 188,595 | 9,590 | 10.7 K to 9.6 K (-10.29 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 9.17 | 1,100 | 10,087 | 10,690 | 9.6 K to 10.7 K (+11.47 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 172.65 | 1,200 | 207,180 | 9,590 | 10.8 K to 9.6 K (-11.12 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 9.17 | 1,200 | 11,004 | 10,790 | 9.6 K to 10.8 K (+12.51 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 173.63 | 5,035 | 874,227 | 9,590 | 14.6 K to 9.6 K (-34.43 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 9.17 | 5,035 | 46,171 | 14,625 | 9.6 K to 14.6 K (+52.50 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 174.46 | 6,565 | 1,145,330 | 9,590 | 16.2 K to 9.6 K (-40.64 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 9.17 | 6,565 | 60,201 | 16,155 | 9.6 K to 16.2 K (+68.46 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 175.14 | 1,100 | 192,654 | 9,590 | 10.7 K to 9.6 K (-10.29 %) |
Nov 27 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 9.17 | 1,100 | 10,087 | 10,690 | 9.6 K to 10.7 K (+11.47 %) |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 15.01 | 13,714 | 205,847 | 0 | |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 15.01 | 1,286 | 19,303 | 13,714 | |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 150.00 | 13,714 | 2,057,100 | 9,590 | 23.3 K to 9.6 K (-58.85 %) |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 15.01 | 13,714 | 205,847 | 23,304 | 9.6 K to 23.3 K (+143.00 %) |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 150.00 | 1,286 | 192,900 | 9,590 | 10.9 K to 9.6 K (-11.82 %) |
Sep 06 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 15.01 | 1,286 | 19,303 | 10,876 | 9.6 K to 10.9 K (+13.41 %) |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.80 | 12,910 | 242,708 | 0 | |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 18.80 | 2,090 | 39,292 | 12,910 | |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 125.00 | 12,910 | 1,613,750 | 9,590 | 22.5 K to 9.6 K (-57.38 %) |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.80 | 12,910 | 242,708 | 22,500 | 9.6 K to 22.5 K (+134.62 %) |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 125.00 | 2,090 | 261,250 | 9,590 | 11.7 K to 9.6 K (-17.89 %) |
Apr 19 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 18.80 | 2,090 | 39,292 | 11,680 | 9.6 K to 11.7 K (+21.79 %) |
Jan 04 2012 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 57.11 | 15,000 | 856,650 | 15,000 | |
Aug 11 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 28.81 | 4,000 | 115,240 | 0 | |
Aug 11 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 28.81 | 4,000 | 115,240 | 9,590 | 5.6 K to 9.6 K (+71.56 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 28.81 | 7,662 | 220,742 | 4,000 | |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 28.81 | 3,138 | 90,406 | 11,662 | |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 28.81 | 200 | 5,762 | 14,800 | |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 57.40 | 7,662 | 439,799 | 5,590 | 13.3 K to 5.6 K (-57.82 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 28.81 | 7,662 | 220,742 | 13,252 | 5.6 K to 13.3 K (+137.07 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 56.56 | 3,138 | 177,485 | 5,590 | 8.7 K to 5.6 K (-35.95 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 28.81 | 3,138 | 90,406 | 8,728 | 5.6 K to 8.7 K (+56.14 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 55.94 | 200 | 11,188 | 5,590 | 5.8 K to 5.6 K (-3.45 %) |
Jul 05 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 28.81 | 200 | 5,762 | 5,790 | 5.6 K to 5.8 K (+3.58 %) |
Jan 04 2011 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 33.42 | 15,000 | 501,300 | 15,000 | |
Jun 03 2010 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 25.43 | 5,000 | 127,150 | 0 | |
Jun 03 2010 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 25.43 | 5,000 | 127,150 | 5,590 | 590 to 5.6 K (+847.46 %) |
Jan 06 2010 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 24.41 | 15,000 | 366,150 | 15,000 | |
Feb 24 2009 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.66 | 10,000 | 76,600 | 0 | |
Feb 24 2009 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.16 | 10,000 | 181,600 | 590 | 10.6 K to 590 (-94.43 %) |
Feb 24 2009 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.66 | 10,000 | 76,600 | 10,590 | 590 to 10.6 K (+1,694.92 %) |
Jan 05 2009 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 18.61 | 15,000 | 279,150 | 15,000 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 2,000 | 15,814 | 0 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 310 | 2,451 | 2,000 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 600 | 4,744 | 2,310 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 100 | 791 | 2,910 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 1,790 | 14,154 | 3,010 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 100 | 791 | 4,800 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 600 | 4,744 | 4,900 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 100 | 791 | 5,500 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 100 | 791 | 5,600 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 2,244 | 17,743 | 5,700 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 17 | 134 | 7,944 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 500 | 3,954 | 7,961 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 100 | 791 | 8,461 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 1,100 | 8,698 | 8,561 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | M | 7.91 | 339 | 2,680 | 9,661 | |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.67 | 2,000 | 37,340 | 590 | 2.6 K to 590 (-77.22 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 2,000 | 15,814 | 2,590 | 590 to 2.6 K (+338.98 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.76 | 310 | 5,816 | 590 | 900 to 590 (-34.44 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 310 | 2,451 | 900 | 590 to 900 (+52.54 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.68 | 600 | 11,208 | 590 | 1.2 K to 590 (-50.42 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 600 | 4,744 | 1,190 | 590 to 1.2 K (+101.69 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.69 | 100 | 1,869 | 590 | 690 to 590 (-14.49 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 100 | 791 | 690 | 590 to 690 (+16.95 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.73 | 1,790 | 33,527 | 590 | 2.4 K to 590 (-75.21 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 1,790 | 14,154 | 2,380 | 590 to 2.4 K (+303.39 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.71 | 100 | 1,871 | 590 | 690 to 590 (-14.49 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 100 | 791 | 690 | 590 to 690 (+16.95 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.77 | 600 | 11,262 | 590 | 1.2 K to 590 (-50.42 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 600 | 4,744 | 1,190 | 590 to 1.2 K (+101.69 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.74 | 100 | 1,874 | 590 | 690 to 590 (-14.49 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 100 | 791 | 690 | 590 to 690 (+16.95 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 18.75 | 100 | 1,875 | 590 | 690 to 590 (-14.49 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 100 | 791 | 690 | 590 to 690 (+16.95 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 19.00 | 2,244 | 42,636 | 590 | 2.8 K to 590 (-79.18 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 2,244 | 17,743 | 2,834 | 590 to 2.8 K (+380.34 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 19.04 | 17 | 324 | 590 | 607 to 590 (-2.80 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 17 | 134 | 607 | 590 to 607 (+2.88 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Sell | S | 19.05 | 500 | 9,525 | 590 | 1.1 K to 590 (-45.87 %) |
Feb 15 2008 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Buy | M | 7.91 | 500 | 3,954 | 1,090 | 590 to 1.1 K (+84.75 %) |